The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings
暂无分享,去创建一个
P. Bauer | N. Brüggemann | N. Ameziane | A. Rolfs | C. Klein | U. Grittner | C. Beetz | M. Kasten | I. Csoti | E. Vollstedt | A. Westenberger | T. Usnich | V. Skrahina | Natalia Koleva-Alazeh | Toni M. Förster | Hanaa Gaber | Jefri J Paul | Filipa Curado | Xenia Bogdanovic | Selen Zülbahar | Maria Olmedillas | Snezana Skobalj | Jefri J. Paul
[1] C. Shaw,et al. Integrated sequencing and array comparative genomic hybridization in familial Parkinson disease , 2020, Neurology: Genetics.
[2] J. Ferreira,et al. Are genetic and idiopathic forms of Parkinson's disease the same disease? , 2020, Journal of neurochemistry.
[3] A. Singleton,et al. Genetics of Parkinson's disease: An introspection of its journey towards precision medicine , 2020, Neurobiology of Disease.
[4] E. Tolosa,et al. LRRK2 in Parkinson disease: challenges of clinical trials , 2020, Nature Reviews Neurology.
[5] P. Chan,et al. Decreased Penetrance of Parkinson's Disease in Elderly Carriers of Glucocerebrosidase Gene L444P/R Mutations: A Community‐Based 10‐Year Longitudinal Study , 2020, Movement disorders : official journal of the Movement Disorder Society.
[6] C. Shaw,et al. Integrated Sequencing & Array Comparative Genomic Hybridization in Familial Parkinson’s Disease , 2019 .
[7] K. Marder,et al. Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists , 2019, Genetics in Medicine.
[8] P. Bauer,et al. Comprehensive clinical, biochemical and genetic screening reveals four distinct GBA genotypes as underlying variable manifestation of Gaucher disease in a single family , 2019, Molecular genetics and metabolism reports.
[9] Sonja W. Scholz,et al. Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms , 2019, Movement disorders : official journal of the Movement Disorder Society.
[10] Yoshihiro Kokubo,et al. Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet Neurology.
[11] I. König,et al. Genotype‐phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review , 2018, Movement disorders : official journal of the Movement Disorder Society.
[12] A. Stepan,et al. LRRK2 activation in idiopathic Parkinson’s disease , 2018, Science Translational Medicine.
[13] I. König,et al. Genotype‐Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review , 2018, Movement disorders : official journal of the Movement Disorder Society.
[14] Peng Wang,et al. The genetics of Parkinson disease , 2018, Ageing Research Reviews.
[15] T. Strom,et al. Diagnostic exome sequencing in early‐onset Parkinson's disease confirms VPS13C as a rare cause of autosomal‐recessive Parkinson's disease , 2018, Clinical genetics.
[16] E. Tolosa,et al. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestry , 2017, Movement disorders : official journal of the Movement Disorder Society.
[17] A. Lang,et al. Precision medicine for disease modification in Parkinson disease , 2017, Nature Reviews Neurology.
[18] T. Foroud,et al. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study , 2016, The Lancet Neurology.
[19] Carlos Cruchaga,et al. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s Disease , 2016, Molecular Neurodegeneration.
[20] A. Lang,et al. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force , 2016, Movement disorders : official journal of the Movement Disorder Society.
[21] C. Klein,et al. Primary familial brain calcification with known gene mutations: a systematic review and challenges of phenotypic characterization. , 2015, JAMA neurology.
[22] J. Hardy,et al. Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains , 2012, Annals of neurology.
[23] P. Pollak,et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers , 2012, Neurology.
[24] D. Dickson,et al. Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation , 2010, Neurodegenerative Diseases.
[25] A. Singleton,et al. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. , 2009, Brain : a journal of neurology.
[26] T. Foroud,et al. Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset , 2009, Neurology.
[27] C. Tanner,et al. Epidemiology of Parkinson's disease , 2007, Handbook of Clinical Neurology.
[28] P. Silburn,et al. Parkinson's disease and family history. , 2006, Parkinsonism & related disorders.
[29] J. Lupski,et al. Whole-Exome Sequencing in Familial Parkinson Disease. , 2016, JAMA neurology.
[30] M. Vidailhet,et al. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease. , 2011, Human molecular genetics.